Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 2061935, 7 pages
https://doi.org/10.1155/2017/2061935
Research Article

Depression and Anxiety Scores Are Associated with Amygdala Volume in Cushing’s Syndrome: Preliminary Study

1Endocrinology/Medicine Departments, Hospital Sant Pau, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER, Unidad 747), IIB-Sant Pau, ISCIII and Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
2Neuroradiology Unit, Hospital de Sant Pau and IIB-Sant Pau, UAB, Barcelona, Spain
3INNDACYT, Avda. Europa 20, Planta Baja Puerta D 08907, Hospitalet de Llobregat, Spain

Correspondence should be addressed to Alicia Santos; tac.uaptnas@sotnasa

Received 2 February 2017; Revised 31 March 2017; Accepted 26 April 2017; Published 18 May 2017

Academic Editor: Margaret A. Niznikiewicz

Copyright © 2017 Alicia Santos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Arnaldi, A. Angeli, A. B. Atkinson et al., “Diagnosis and complications of Cushing’s syndrome: a consensus statement,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 12, pp. 5593–5602, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. L. K. Nieman, B. M. Biller, J. W. Findling et al., “The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline,” The Journal of Clinical Endocrinology & Metabolism, vol. 93, pp. 1526–1540, 2008. View at Google Scholar
  3. I. Bourdeau, C. Bard, H. Forget, Y. Boulanger, H. Cohen, and A. Lacroix, “Cognitive function and cerebral assessment in patients who have Cushing's syndrome,” Endocrinology and Metabolism Clinics of North America, vol. 34, no. 2, pp. 357–369, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. N. Starkman, D. E. Schteingart, and M. A. Schork, “Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels,” Psychosomatic Medicine, vol. 43, no. 1, pp. 3–18, 1981. View at Publisher · View at Google Scholar · View at Scopus
  5. M. N. Starkman, B. Giordani, S. Berent, M. A. Schork, and D. E. Schteingart, “Elevated cortisol levels in Cushing's disease are associated with cognitive decrements,” Psychosomatic Medicine, vol. 63, no. 6, pp. 985–993, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. M. O. van Aken, A. M. Pereira, N. R. Biermasz et al., “Quality of life in patients after long-term biochemical cure of Cushing's disease,” The Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 6, pp. 3279–3286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. J. R. Lindsay, T. Nansel, S. Baid, J. Gumowski, and L. K. Nieman, “Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission,” The Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 2, pp. 447–453, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. N. Starkman, S. S. Gebarski, S. Berent, and D. E. Schteingart, “Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome,” Biological Psychiatry, vol. 32, no. 9, pp. 756–765, 1992. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Santos, E. Resmini, I. Crespo et al., “Small cerebellar cortex volume in patients with active Cushing's syndrome,” European Journal of Endocrinology, vol. 171, no. 4, pp. 461–469, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Bourdeau, C. Bard, B. Noël et al., “Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism,” The Journal of Clinical Endocrinology & Metabolism, vol. 87, no. 5, pp. 1949–1954, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Resmini, A. Santos, B. Gómez-Anson et al., “Verbal and visual memory performance and hippocampal volumes, measured by 3-tesla magnetic resonance imaging, in patients with Cushing's syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 2, pp. 663–671, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Caudal, T. M. Jay, and B. P. Godsil, “Behavioral stress induces regionally-distinct shifts of brain mineralocorticoid and glucocorticoid receptor levels,” Frontiers in Behavioral Neuroscience, vol. 8, article 19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. C. D. Andela, S. J. A. Van Der Werff, J. N. Pannekoek et al., “Smaller grey matter volumes in the anterior cingulate cortex and greater cerebellar volumes in patients with long-term remission of Cushing's disease: a case-control study,” European Journal of Endocrinology, vol. 169, no. 6, pp. 811–819, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. A. A. Rasia-Filho, R. G. Londero, and M. Achaval, “Functional activities of the amygdala: an overview,” Journal of Psychiatry and Neuroscience, vol. 25, no. 1, pp. 14–23, 2000. View at Google Scholar · View at Scopus
  15. L. R. Johnson, C. Farb, J. H. Morrison, B. S. McEwen, and J. E. LeDoux, “Localization of glucocorticoid receptors at postsynaptic membranes in the lateral amygdala,” Neuroscience, vol. 136, no. 1, pp. 289–299, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. D. P. Merke, J. N. Giedd, M. F. Keil et al., “Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 5, pp. 2531–2536, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. F. S. Maheu, L. Mazzone, D. P. Merke et al., “Altered amygdala and hippocampus function in adolescents with hypercortisolemia: a functional magnetic resonance imaging study of Cushing syndrome,” Development and Psychopathology, vol. 20, no. 4, pp. 1177–1189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. Bas-Hoogendam, C. D. Andela, S. J. A. van der Werff et al., “Altered neural processing of emotional faces in remitted Cushing's disease,” Psychoneuroendocrinology, vol. 59, pp. 134–146, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. R. C. Oldfield, “The assessment and analysis of handedness: the Edinburgh inventory,” Neuropsychologia, vol. 9, no. 1, pp. 97–113, 1971. View at Publisher · View at Google Scholar · View at Scopus
  20. M.-J. Barahona, N. Sucunza, E. Resmini et al., “Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 9, pp. 3365–3371, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. T. Beck, R. A. Steer, and G. K. Brown, Beck Depression Inventory, Pearson, Madrid, Spain, 2nd edition, 2011.
  22. C. D. Spielberger, R. L. Gorsuch, and R. E. Lushene, STAI, Manual for the State-Trait Inventory, TEA Ediciones, Madrid, Spain, 2008.
  23. F. Ségonne, A. M. Dale, E. Busa et al., “A hybrid approach to the skull stripping problem in MRI,” NeuroImage, vol. 22, no. 3, pp. 1060–1075, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Fischl, D. H. Salat, E. Busa et al., “Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain,” Neuron, vol. 33, no. 3, pp. 341–355, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Fischl, D. H. Salat, A. J. W. van der Kouwe et al., “Sequence-independent segmentation of magnetic resonance images,” NeuroImage, vol. 23, supplement 1, pp. S69–S84, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. C. D. Fowler, Y. Liu, and Z. Wang, “Estrogen and adult neurogenesis in the amygdala and hypothalamus,” Brain Research Reviews, vol. 57, no. 2, pp. 342–351, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Ding, F. Han, and Y. Shi, “Single-prolonged stress induces apoptosis in the amygdala in a rat model of post-traumatic stress disorder,” Journal of Psychiatric Research, vol. 44, no. 1, pp. 48–55, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. A. J. Bhatt, Y. Feng, J. Wang, M. Famuyide, and K. Hersey, “Dexamethasone induces apoptosis of progenitor cells in the subventricular zone and dentate gyrus of developing rat brain,” Journal of Neuroscience Research, vol. 91, no. 9, pp. 1191–1202, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Wang, L. S. Barak, R. A. Mook, and W. Chen, “Glucocorticoid hedgehog agonists in neurogenesis,” Vitamins and Hormones, vol. 87, pp. 207–215, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. D. A. Tata, V. A. Marciano, and B. J. Anderson, “Synapse loss from chronically elevated glucocorticoids: Relationship to neuropil volume and cell number in hippocampal area CA3,” Journal of Comparative Neurology, vol. 498, no. 3, pp. 363–374, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. J. K. Kleen, M. T. Sitomer, P. R. Killeen, and C. D. Conrad, “Chronic stress impairs spatial memory and motivation for reward without disrupting motor ability and motivation to explore,” Behavioral Neuroscience, vol. 120, no. 4, pp. 842–851, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. M. N. Starkman, B. Giordani, S. S. Gebarski, S. Berent, M. A. Schork, and D. E. Schteingart, “Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease,” Biological Psychiatry, vol. 46, no. 12, pp. 1595–1602, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Burkhardt, D. Lüdecke, L. Spies, L. Wittmann, M. Westphal, and J. Flitsch, “Hippocampal and cerebellar atrophy in patients with Cushing's disease,” Neurosurgical Focus, vol. 39, no. 5, article E5, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Baas, A. Aleman, and R. S. Kahn, “Lateralization of amygdala activation: a systematic review of functional neuroimaging studies,” Brain Research Reviews, vol. 45, no. 2, pp. 96–103, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. R. S. Hastings, R. V. Parsey, M. A. Oquendo, V. Arango, and J. J. Mann, “Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression,” Neuropsychopharmacology, vol. 29, no. 5, pp. 952–959, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Mervaala, J. Föhr, M. Könönen et al., “Quantitative MRI of the hippocampus and amygdala in severe depression,” Psychological Medicine, vol. 30, no. 1, pp. 117–125, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Egger, M. Schocke, E. Weiss et al., “Pattern of brain atrophy in elderly patients with depression revealed by voxel-based morphometry,” Psychiatry Research—Neuroimaging, vol. 164, no. 3, pp. 237–244, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. W. F. Kelly, “Psychiatric aspects of Cushing’s syndrome,” Quarterly Medical Journal, vol. 89, pp. 543–551, 1996. View at Google Scholar
  39. L. D. Dorn, E. S. Burgess, B. Dubbert et al., “Psychopathology in patients with endogenous Cushing's syndrome: 'Atypical' or melancholic features,” Clinical Endocrinology, vol. 43, no. 4, pp. 433–442, 1995. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Tiemensma, N. R. Biermasz, H. A. M. Middelkoop, R. C. van der Mast, J. A. Romijn, and A. M. Pereira, “Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing's disease,” The Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 10, pp. E129–E141, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Sonino and G. A. Fava, “Psychiatric disorders associated with Cushing's syndrome: epidemiology, pathophysiology and treatment,” CNS Drugs, vol. 15, no. 5, pp. 361–373, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Sonino, F. Fallo, and G. A. Fava, “Psychosomatic aspects of Cushing's syndrome,” Reviews in Endocrine and Metabolic Disorders, vol. 11, no. 2, pp. 95–104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Mahajan, A. Crown, S. Checkley, A. Farmer, and S. Lightman, “Atypical depression in growth hormone deficient adults, and the beneficial effects of growth hormone treatment on depression and quality of life,” European Journal of Endocrinology, vol. 151, no. 3, pp. 325–332, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. M. D. Lezak, D. B. Howieson, and D. W. Loring, Neuropsychological Assessment, Oxford University Press, New York, NY, USA, 4th edition, 2004.
  45. B. Bülow, L. Hagmar, P. Ørbæk, K. Österberg, and E. M. Erfurth, “High incidence of mental disorders, reduced mental well-being and cognitive function in hypopituitary women with GH deficiency treated for pituitary disease,” Clinical Endocrinology, vol. 56, no. 2, pp. 183–193, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Blackmon, W. B. Barr, C. Carlson et al., “Structural evidence for involvement of a left amygdala-orbitofrontal network in subclinical anxiety,” Psychiatry Research—Neuroimaging, vol. 194, no. 3, pp. 296–303, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. F. Hayano, M. Nakamura, T. Asami et al., “Smaller amygdala is associated with anxiety in patients with panic disorder,” Psychiatry and Clinical Neurosciences, vol. 63, no. 3, pp. 266–276, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. T. D. Wager, K. L. Phan, I. Liberzon, and S. F. Taylor, “Valence, gender, and lateralization of functional brain anatomy in emotion: a meta-analysis of findings from neuroimaging,” NeuroImage, vol. 19, no. 3, pp. 513–531, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. W. Sato, T. Kochiyama, Y. Kubota et al., “The association between perceived social support and amygdala structure,” Neuropsychologia, vol. 85, pp. 237–244, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. J. P. Hamilton, M. Siemer, and I. H. Gotlib, “Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies,” Molecular Psychiatry, vol. 13, no. 11, pp. 993–1000, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. M. N. Starkman, “Neuropsychiatric findings in cushing syndrome and exogenous glucocorticoid administration,” Endocrinology and Metabolism Clinics of North America, vol. 42, no. 3, pp. 477–488, 2013. View at Publisher · View at Google Scholar · View at Scopus